Innova Captab Limited — Important, 07-11-2025: Updates
07-11-2025 | 05:24 pm
07-11-2025 | 05:24 pm
Innova Captab's board approved its financial results for the quarter and half-year. Standalone half-year revenue reached ₹576.81 Cr, with profit at ₹34.63 Cr and EPS of ₹6.05. Additionally, Mr. Devendra Ganpatrav Palav, CEO of subsidiary Sharon Bio-Medicine, was re-designated as Manager to boost executive leadership and operational excellence.
No comments yet. Be the first to comment!
